Table 3. Concordance between biopsy, primary tumor and corresponding disseminated lymph nodes and distant metastases in patients with breast cancer and NSCLC.
Degree of concordance | Breast cancer patients No. (%) | NSCLC patients, adenocarcinoma No. (%) | NSCLC patients, SCC, No. (%) |
---|---|---|---|
Concordance of FRα status | |||
Biopsy = Primary tumor | 27 out of 40 (67.5) | 10 out of 12 (83) | 10 out of 11 (91) |
Primary tumor = Local metastasis | 12 out of 20 (60) | 31 out of 42 (78)* | 13 out of 18 (80)* |
Primary tumor = Distant metastases | 12 out of 15 (80) | 7 out of 8 (88) | |
Disconcordance of FRα status | |||
Biopsy > Primary tumor | 2 | 1 | 0 |
Biopsy < Primary tumor | 11 | 1 | 1 |
Primary tumor > Local metastasis | 6 | 4 | 2 |
Primary tumor < Local metastasis | 2 | 0 | 3 |
Primary tumor > Distant metastasis | 2 | 1 | |
Primary tumor < Distant metastasis | 1 | 0 |
Abbreviations: SCC squamous cell carcinoma; FRα Folate receptor α; pos LN positive lymph node * LN expression was assessed in 33 patients, in respectively 18 patients with adenocarcinoma and 15 patients with SCC; concordance was seen in 14 out of 18 adenocarcinoma patients (31/42 LNs) and 12 out of 15 SCC patients (13/18 LNs).